首页 | 本学科首页   官方微博 | 高级检索  
检索        

紫杉醇联合氟尿嘧啶、顺铂治疗晚期胃癌临床疗效观察
引用本文:李玫,刘艳秋,唐立民.紫杉醇联合氟尿嘧啶、顺铂治疗晚期胃癌临床疗效观察[J].中国当代医药,2013(5):41-41,44.
作者姓名:李玫  刘艳秋  唐立民
作者单位:吉林省肿瘤医院,吉林长春130012
摘    要:目的探讨紫杉醇联合氟尿嘧啶、顺铂治疗晚期胃癌的临床疗效。方法选取2010年5月~2012年5月本院收治的晚期胃癌患者共134例,分成治疗组和对照组,各67例,治疗组采用紫杉醇联合氟尿嘧啶、顺铂治疗,对照组采用氟尿嘧啶和顺铂治疗。结果治疗组显效率和总有效率分别为59.70%(40/67),91.04%(61/67);对照组显效率和总有效率分别为40.30%(27/67),68.66%(46/67),两组比较,差异有统计学意义(P〈0.05)。结论紫杉醇联合氟尿嘧啶、顺铂治疗晚期胃癌能够明显改善患者的临床症状,提高其生活质量。

关 键 词:晚期胃癌  紫杉醇  氟尿嘧啶  顺铂  临床疗效

Clinical observation of Paclitaxel combined with Fluorouracil and Cis- platin in treatment of advanced gastric cancer
Authors:LI Mei  LIU Yanqiu  TANG Limin
Institution:(Tumor Hospital of Jilin Province, Changchun 130012, China)
Abstract:Objective To explore the curative effect of advanced gastric cancer treated with Paclitaxel, Fluorouracil and Cisplatin. Methods One hundred and thirty-four patients with advanced gastric cancer was divided in two groups. The treatment group was given Paclitaxel plus Fluorouracil, Cisplatin treatment, the control group was given Fluo- rouracil plus Cisplatin treatment. Results The obvious effective rate and the total effective rate of treatment group were 59.70%(40/67) and 91.04%(61/67) respectively; the obvious effective rate and the total effective rate of control group were 40.30%(27/67) and 68.66%(46/67) respectively, there was significant difference between two groups (P 〈 0.05). Conclusion Paclitaxel combined with Fluorouraeil and Cisplatin in the treatment of advanced gastric cancer can sig- nificantly improve the patients" clinical symptoms and improve their quality of life.
Keywords:Advanced gastric cance  Paclitaxel  Fluorouracil  Cisplatin  Clinical efficacy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号